Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Layton Center Clinical Data Resources Resource Report Resource Website |
Layton Center Clinical Data Resources (RRID:SCR_008822) | data or information resource, database | A database housing longitudinal relational research data from over 4,000 research subjects. The database includes the following types of data: physical and neurological exam findings, neurocognitive test scores, personal and family history of dementia, personal demographic genotypes (APOE, HLA), age at service evaluations, age at onset, age at death, clinical diagnosis, neuropathology diagnosis, tissue inventory information (when available), health status, medications, laboratory tests, and MRI data. | clinical data, alzheimer's disease, dementia, genotype, late adult human, longitudinal, clinical, mri |
is related to: Oregon Brain Bank has parent organization: OHSU Layton Aging and Alzheimer's Disease Center |
Aging, Alzheimer's disease | Researchers must submit a request | nlx_144446 | SCR_008822 | Layton Aging and Alzheimer's Disease Center Clinical Data Resources | 2026-08-03 09:34:12 | 0 | |||||||
|
Alzheimer Disease and Frontotemporal Dementia Mutation Database Resource Report Resource Website 1+ mentions |
Alzheimer Disease and Frontotemporal Dementia Mutation Database (RRID:SCR_008286) | data or information resource, database | A locus-specific database aimed at collecting known mutations and non-pathogenic coding variations in the genes related to Alzheimer disease (AD) and frontotemporal dementia (FTD), following the guidelines of the Human Genome Variation Society. Mutations can be retrieved based on the gene, phenotype and publication. The database contains mutations reported in the literature and at scientific meetings, and unpublished mutations directly submitted to the database. To date, AD&FTDMDB contains mutations in the genes encoding the Amyloid Beta Precursor Protein (APP), Presenilin 1 (PSEN1), Presenilin 2 (PSEN2), Chromatin Modifying Protein 2B (CHMP2B), fusion (involved in t(12;16) in malignant liposarcoma) (FUS), Granulin (GRN), Microtubule Associated Protein Tau (MAPT), TAR DNA binding protein (TARDBP) and Valosin-containing Protein (VCP) and holds 415 different mutations observed in 1027 patients or families. As of March 2013, the latest publications referenced were from 2008, indicating that this resource may not be up to date. | frontotemporal dementia, gene, alzheimers disease, genome, mrna, mutation, phenotype, single nucleotide polymorphism | has parent organization: University of Antwerp; Antwerp; Belgium | Alzheimer's disease, Frontotemporal dementia | PMID:17392794 | r3d100012441, nif-0000-23934 | https://doi.org/10.17616/R3277G, https://doi.org/10.17616/R3277G | SCR_008286 | ADandFTDMDB, AD and FTD Mutation Database | 2026-08-03 09:33:58 | 7 | ||||||
|
Brain Health Registry Resource Report Resource Website 10+ mentions |
Brain Health Registry (RRID:SCR_010230) | Brain Health Registry | people resource, patient registry | A website aimed at recruiting and assessing subjects for all types of neuroscience studies with the internet. The hope is to accelerate various types of observational studies and clinical trials, and also reduce costs. They are interested in having people, including healthy subjects of all ages, join the registry. Joining only takes a few minutes. The web-based project is designed to speed up cures for Alzheimer's, Parkinson's and other brain disorders. It uses online questionnaires and online neuropsychological tests (which are very much like online brain games). | questionnaire, brain test, brain, health, neuropsycholgoical test, game, clinical trial | has parent organization: University of California at San Francisco; California; USA | Alzheimer's disease, Parkinson's disease, Depressive Disorder, Traumatic brain injury, Brain disorder, Post-Traumatic Stress Disorder, Aging | Free, The community can contribute to this resource | nlx_156798 | SCR_010230 | 2026-08-03 09:34:32 | 11 | |||||||
|
Resources for Enhancing Alzheimers Caregiver Health Resource Report Resource Website |
Resources for Enhancing Alzheimers Caregiver Health (RRID:SCR_003638) | REACH | data or information resource, data set | Data set from six research sites that examined the feasibility and outcomes of the most promising home and community-based intervention approaches for enhancing family caregiving for Alzheimers Disease (AD) and related disorders (ADRD). A unique feature is the examination of AD burdens and interventions in three ethnic groups (Caucasians, Hispanics, and African Americans). Caregiver/care recipient dyads are entered into the study using standardized eligibility criteria. The dyads are randomized at each intervention site using site-specific procedures. Standardized assessment batteries are administered at baseline, 6, 12, and 18 months. The five general types of REACH interventions are: Individual Information and Support strategies that increase caregivers' understanding of dementia and their particular caregiving situation; Group Support and Family Systems efforts that provide caregivers with multiple forms of social support; Psychoeducational and Skill-Based Training approaches that teach caregivers coping and behavioral management strategies; Home-Based Environmental interventions that modify the home environment's effect on the care recipient and support the caregiver; and Enhanced Technology Systems such as home-centered computer/telephone networks that are designed to reduce caregiver distress and isolation. REACH II was funded in 2001 to test a single multi-component intervention among family caregivers of persons with ADRD, building upon the findings of REACH. Recruitment for REACH II was completed in January 2004 with 642 participants entering the study across 5 participating sites. | longitudinal, minority, caucasian, hispanic, african american, intervention, caregiver, caregiver burden, emotional state, family, health services utilization, health status, home health care, mental disorder, mental health, late adult human, outreach program, psychological wellbeing, questionnaire, anxiety, caregiver health, health behavior, sociodemographic, medication |
is listed by: Inter-university Consortium for Political and Social Research (ICPSR) has parent organization: University of Pittsburgh; Pennsylvania; USA |
Aging, Alzheimer's disease, Alzheimer's related disorder, Dementia, Stress | NIA ; NINR |
nlx_157789 | http://www.edc.pitt/REACH | SCR_003638 | Resources for Enhancing Alzheimer's Caregiver Health (REACH), Resources for Enhancing Alzheimer's Caregiver Health | 2026-08-03 09:32:12 | 0 | |||||
|
Limited Access Datasets From NIMH Clinical Trials Resource Report Resource Website 1+ mentions |
Limited Access Datasets From NIMH Clinical Trials (RRID:SCR_005614) | Limited Access Datasets From NIMH Clinical Trials | data or information resource, data set | A listing of data sets from NIMH-supported clinical trials. Limited Access Datasets are available from numerous NIMH studies. NIMH requires all investigators seeking access to data from NIMH-supported trials held by NIMH to execute and submit as their request the appropriate Data Use Certification pertaining to the trial. The datasets distributed by NIMH are referred to as limited access datasets because access is limited to qualified researchers who complete Data Use Certifications. | clinical trial, mental health, child |
uses: ClinicalTrials.gov uses: Sequenced Treatment Alternatives to Relieve Depression Study uses: CATIE - Clinical Antipsychotic Trials in Intervention Effectiveness uses: CATIE - Alzheimers Disease uses: Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) uses: TADS - Treatment for Adolescents with Depression Study uses: Treatment of SSRI-resistant Depression in Adolescents (TORDIA) is listed by: re3data.org has parent organization: NIMH Clinical Trials |
Depressive Disorder, Attention deficit-hyperactivity disorder, Autism Spectrum Disorder, Bipolar Disorder, Alzheimer's disease, Anxiety, Schizophrenia, Pervasive Development Disorder | NIMH | Approval required, Data Use Certification required | nlx_146232 | http://www.nimh.nih.gov/funding/clinical-trials-for-researchers/datasets/ | http://www.nimh.nih.gov/trials/datasets/nimh-procedures-for-requesting-data-sets.shtml, http://www.nimh.nih.gov/health/trials/datasets/ | SCR_005614 | Available Limited Access Datasets From NIMH Clinical Trials | 2026-08-03 09:32:44 | 1 | |||
|
Orion Resource Report Resource Website 10+ mentions |
Orion (RRID:SCR_003911) | Orion | commercial organization | A globally operating Finnish developer, manufacturer and marketer of human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. They are continuously developing new drugs and treatment methods. Pharmaceutical RD focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. | pharmaceutical, drug, diagnostic test, diagnostic, central nervous system, drug, oncology, critical care, pulmonary, central nervous system drug, pulmonary drug, cancer, veterinary drug, medicine, clinical, hygiene monitoring |
is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
Cancer, Asthma, Alzheimer's disease, Parkinson's disease, Breast cancer, Prostate cancer | nlx_158257 | SCR_003911 | Orion Corporation, Orion Pharma | 2026-08-01 12:02:35 | 34 | |||||||
|
Innovative Concepts in Drug Development Resource Report Resource Website |
Innovative Concepts in Drug Development (RRID:SCR_003940) | ICDD | commercial organization | A contract research organization (CRO) that are mitochondrial experts, operating mitochondrial function screening platforms by using accepted pharmaceutical innovative technologies. The dynamic analysis of several typical markers of central and mitochondrial metabolism, redox status, or mitochondrial biogenesis are included in the determination of bioenergetic balance in living cells of human origin. These platforms are used to validate the activity of pharmaceuticals, cosmetics and environmental assets xenobiotics on mitochondrial targets associated with the activity or toxicity of these products under the selected models. They specialize in the selection of drugs affecting the progression of neurodegenerative diseases and offer proven models of Huntington's disease, Parkinson's and Alzheimer's, using primary cells of human origin. They have developed and use technology cellulomique and proteomics to identify early response profiles and clinical safety of pharmaceutical products for diseases of the CNS. | contract research organization, mitochondria, drug development, pharmaceutical, drug, model, toxicity, cosmetic, environment | is related to: PharmaCog | Parkinson's disease, Alzheimer's disease, Neurodegenerative disease, Huntington's disease, Central nervous system disease | Commercial | nlx_158326 | SCR_003940 | ICDD-sas | 2026-08-01 12:02:24 | 0 | ||||||
|
Greek Association of Alzheimers Disease and Related Disorders Resource Report Resource Website |
Greek Association of Alzheimers Disease and Related Disorders (RRID:SCR_003938) | GAADRD | nonprofit organization | A non-profit organization whose aim is to offer advice concerning the care of Alzheimer''''s disease patients, information and services for the people affected and their families. Also, to offer mutual help to the family members of the patients in order to reduce the social, economic and emotional cost deriving from the long care of people suffering from dementia. Lastly, the association attempts to publicize the social needs of the population affected and to inform the public in order to be acquainted with the problem. The mission of the Greek Association of Alzheimer''''s Disease is * the early diagnosis of dementia by scientists * the promotion of research * education and training for all the stakeholders * the development of Care Units for patients with Alzheimer''''s Disease * the provision of useful information and advise (24 hour help-line) on dementia problems (caring, legal or financial issues) * the presentation of lectures by health professionals and informal carers, covering all aspects of Alzheimer Disease * and the development of professional seminars during the whole year. | late adult human |
is related to: Alzheimer Europe is related to: PharmaCog is related to: Alzheimers Disease International |
Alzheimer's disease, Dementia, Aging | nlx_158314, grid.428867.7 | https://ror.org/04xqgyf78 | SCR_003938 | Greek Association of Alzheimer Disease and Relative Disorders, Greek Association of Alzheimer Disease and Related Disorders, Alzheimer Hellas, Greek Association of Alzheimer's Disease and Related Disorders | 2026-08-01 12:02:28 | 0 | ||||||
|
Eisai Resource Report Resource Website 10+ mentions |
Eisai (RRID:SCR_003936) | Eisai | commercial organization | A global pharmaceutical company. | pharmaceutical, healthcare, drug, oncology, central nervous system, neurology, medicine | is related to: PharmaCog | Cancer, Epilepsy, Alzheimer's disease, Obesity, Immune-mediated disease, Insomnia | grid.418767.b, Wikidata: Q29123933, nlx_158312, ISNI: 0000 0004 0599 8842 | https://ror.org/0469x1750 | SCR_003936 | Eisai Co. Ltd., EISAI Ltd | 2026-08-01 12:02:24 | 16 | ||||||
|
Alzheimer's Plan Foundation Resource Report Resource Website |
Alzheimer's Plan Foundation (RRID:SCR_004032) | National Institute of Health and Medical Research; Rennes; France | institution | A non-profit registered French charity that provides a research on Alzheimer's disease and related disorders program with the following goals: * create a dynamic national and international collaborative research of the fundamental absorptions, * densify the network of public and private researchers with an attractive policy * install infrastructure basic, clinical and laboratory performing research * promote interaction with the health industries to reduce development time. At the national level the Foundation has implemented measures Research Plan, through: * animation fabric French medical and scientific research, * coordination of research initiatives * the implementation of actions, * support for specific projects. Internationally, the Foundation is at the origin of an international mobilization of researchers, initiated during the French Presidency of the European Union. Called Joint Programming, this pilot initiative involves 23 countries will coordinate their efforts at European level research on neurodegenerative diseases, especially Alzheimer's disease. | late adult human, alzheimer, portal, funding resource | is related to: International Genomics of Alzheimers Project | Alzheimer's disease, Neurodegenerative disease | French Ministry of Higher Education and Research | nlx_158458, Crossref funder ID: 501100007494, grid.478982.8 | https://ror.org/00kr4dx39 | SCR_004032 | Alzheimers Plan Foundation, Fondation Plan Alzheimer | 2026-08-01 12:02:30 | 0 | |||||
|
Proteome Sciences Resource Report Resource Website 1+ mentions |
Proteome Sciences (RRID:SCR_004106) | PS | commercial organization | Commercial company delivering content for personalized medicine in the areas of Biomarker Services, Biomarker Assays, Isobaric and Isotopic Reagents and Proprietary Biomarkers. A global leader in applied proteomics, they use high sensitivity proprietary technologies to detect biomarkers (differentially expressed proteins in diseases) and to develop rapid assays for testing. The biomarkers discovered in body fluids or tissues are validated, developed and commercialized as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing. | protein, peptide, biomarker, pharmaceutical, diagnostic, electrophoretics ltd, electrophoretics, proteomics, assay, isobaric, isotopic, reagent, personalized medicine, mass spectrometry, tandem mass tag | is related to: EMIF | Neurodegenerative disorder, Cancer, Stroke, Alzheimer's disease, Traumatic brain injury | nlx_158582 | SCR_004106 | Proteome Science, Proteome Sciences plc | 2026-08-01 12:02:30 | 3 | |||||||
|
Foundation for the National Institutes of Health Resource Report Resource Website 1000+ mentions |
Foundation for the National Institutes of Health (RRID:SCR_004493) | FNIH | institution | A public charity whose mission is to support the NIH in its mission to improve health, by forming and facilitating public-private partnerships for biomedical research and training. Its vision is Building Partnerships for Discovery and Innovation to Improve Health. The FNIH draws together the world''s foremost researchers and resources, pressing the frontier to advance critical discoveries. They are recognized as the number-one medical research charity in the countryleveraging support, and convening high level partnerships, for the greatest impact on the most urgent medical challenges we face today. Grants are awarded as part of a public-private partnership with the National Heart, Lung, and Blood Institute (NHLBI) on behalf of The Heart Truth in support of women''s heart health education and research. Funding for the Community Action Program is provided by the FNIH through donations from individuals and corporations including The Heart Truth partners Belk Department Stores, Diet Coke, and Swarovski. Successful biomedical research relies upon the knowledge, training and dedication of those who conduct it. Bringing multiple disciplines to bear on health challenges requires innovation and collaboration on the part of scientists. Foundation for NIH partnerships operate in a variety of ways and formats to recruit, train, empower and retain their next generation of researchers. From lectures and multi-week courses, to scholarships and awards through fellowships and residential training programs, their programs respond to the needs of scientists at every level and stage in their careers. | biomedical research |
is related to: Osteoarthritis Biomarkers Project (OABP) is parent organization of: Biomarkers Consortium is parent organization of: Observational Medical Outcomes Partnership is parent organization of: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is parent organization of: Accelerating Medicines Partnership - Alzheimers is parent organization of: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is parent organization of: Genetic Association Information Network (GAIN) |
Type 1 diabetes, Type 2 diabetes, Diabetes, Metabolic disease, Alzheimer's disease, Schizophrenia, Prostate cancer, Demantia, Muscular dystrophy, Tuberculosis, HIV, Parkinson's disease, Osteoarthritis, Age-related eye disease, Visceral leishmaniasis, Undiagnosed disease, Cancer, Non-small cell lung cancer, Malaria, Systemic lupus erythematosus, COVID-19, Acute lymphoblastic leukemia | ISNI: 0000 0000 9836 9834, Wikidata: Q16837497, nlx_143768, Crossref funder ID: 100000009, grid.428807.1 | https://ror.org/00k86s890 | SCR_004493 | Foundation for NIH | 2026-08-01 12:02:39 | 1788 | ||||||
|
Stereology Resource Center Resource Report Resource Website 1+ mentions |
Stereology Resource Center (RRID:SCR_003137) | SRC | commercial organization | A company of professionally trained stereologists, bioscientists, computer engineers, educators, and support personnel that provides comprehensive neurostereology products and services to the global bioscience community. These products and services include: stereology and image analysis software, digital imaging technology, turnkey stereologer solutions, comprehensive stereology and image analysis/image processing software, professional contract services, neurostereology workshops, basic stereology courses, and online stereology webinars. The Center also offers tissue processing (sectioning, staining, slide preparation) and stereology data collection services. Researchers may use equipment and facilities to complete projects with full confidentiality and according to Good Laboratory Practices guidelines. | neurostereology, stereology, alzheimer's disease, parkinson's disease, neuronal morphology, neuronal stereology, microscopy, stereology consultation, webinar, workshop, tissue processing, sectioning, staining, slide preparation, data collection, tissue, slide | Alzheimer's disease, Parkinson's disease | Free, Freely available | nlx_156794, grid.492523.b | https://ror.org/02ez32078 | SCR_003137 | SRC - Better Science Through Better Stereology | 2026-08-01 12:02:17 | 4 | ||||||
|
Alzheimer Europe Resource Report Resource Website 1+ mentions |
Alzheimer Europe (RRID:SCR_003802) | AE | nonprofit organization | A non-governmental organization aimed at raising awareness of all forms of dementia by creating a common European platform through co-ordination and co-operation between Alzheimer organizations throughout Europe. Alzheimer Europe is also a source of information on all aspects of dementia. |
is related to: Greek Association of Alzheimers Disease and Related Disorders is related to: PharmaCog is related to: EMIF is parent organization of: PharmaCog |
Dementia, Alzheimer's disease | European Union | ISNI: 0000 0001 0739 010X, Wikidata: Q16827712, nlx_158313, grid.424021.1 | https://ror.org/029yy6d70 | SCR_003802 | 2026-08-01 12:02:33 | 8 | |||||||
|
reMYND Resource Report Resource Website 1+ mentions |
reMYND (RRID:SCR_003824) | reMYND | commercial organization | Organization that drives the development of disease-modifying treatments against Alzheimer's, Parkinson's, Diabetes and other protein misfolding disorders through two independently managed business units: * Contract Research: The in-vivo Contract Research Organization (CRO) helps its clients to assess the pharmacokinetics and -dynamics of their experimental treatments against Alzheimer's disease. The main focus is on efficacy testing of candidate drugs in reMYND's proprietary Alzheimer mouse models expressing the clinical APP-London allele as single transgene or in combination with clinical alleles of human PS1 and TAU. * Drug Discovery: The Drug Discovery and Development Unit (DDD) focuses on disease-modifying treatments against protein-misfolding disorders, such as Alzheimer's disease (tau), Parkinson's disease (-synuclein), and Diabetes. In addition, reMYND grants licenses and markets commercial kits of RadarScreen, a technology for rapid and cost-effective identification of genotoxic liabilities in early stage drug discovery. reMYND has been substantially supported by grants from IWT and from The Michael J Fox Foundation. | protein misfolding | Alzheimer's disease, Parkinson's disease, Diabetes | IWT ; Michael J. Fox Foundation for Parkinson's Research |
nlx_158130 | SCR_003824 | reMYND NV | 2026-08-01 12:02:26 | 1 | |||||||
|
Amorfix Resource Report Resource Website 1+ mentions |
Amorfix (RRID:SCR_003783) | AMF | commercial organization | Product development company focused on therapeutic products and diagnostic devices targeting misfolded protein diseases. On July, 2015 the company name was changed to ProMIS Neurosciences, Inc. | diagnostic, therapy, alzheimer, protein, misfolded protein disease | Alzheimer's disease, Amyotrophic Lateral Sclerosis, Cancer | Crossref funder ID: 100007611, nlx_158072, grid.422608.a | https://ror.org/045rtab03 | SCR_003783 | Amorfix Life Science, Amorfix Life Sciences Ltd., Amorfix Life Sciences, ProMIS Neurosciences | 2026-08-01 12:02:33 | 2 | |||||||
|
Alzheimer's Foundation of America Resource Report Resource Website |
Alzheimer's Foundation of America (RRID:SCR_008724) | AFA | institution | Non profit organization and informational portal directed towards patients and families. AFA is an umbrella orgnization uniting over 1600 member organizations to collaborate on education, resources, best practices and advocacy. AFA provides several grant opportunities for AFA's nonprofit member organizations and to individuals in need. | Alzheimer's disease, human | Alzheimer's disease | Crossref funder ID: 100010473, grid.478408.7, nlx_143655, ISNI: 0000 0004 0432 0095 | https://ror.org/03tkh8741 | SCR_008724 | 2026-08-01 12:04:01 | 0 | ||||||||
|
Oklahoma Medical Research Foundation Resource Report Resource Website 50+ mentions |
Oklahoma Medical Research Foundation (RRID:SCR_005287) | OMRF | institution | A biomedical research institute that aims to understand and develop more effective treatments for human disease, focusing on critical research areas such as heart disease, cancer, lupus and Alzheimer's disease. | human disease, cardiovascular disease, cancer, lupus, alzheimer’s disease, treatment, biomedical research institute |
is parent organization of: C. elegans Gene Knockout Consortium is parent organization of: Oklahoma Medical Research Foundation OMRF Clinical Genomics Center Core Facility |
Heart disease, Cancer, Lupus, Alzheimer's disease | Public | grid.274264.1, ISNI: 0000 0000 8527 6890, Wikidata: Q7082264, nlx_144327, Crossref funder ID: 100008907 | https://ror.org/035z6xf33 | SCR_005287 | 2026-08-01 12:02:49 | 60 | ||||||
|
Alzheimers Association Resource Report Resource Website 100+ mentions |
Alzheimers Association (RRID:SCR_007398) | ALZ | nonprofit organization | A non profit organization dedicated to providing support for patients and families with Alzheimer's disease, to educating the public about the disease, to funding a wide range of Alzheimer's disease related research and to finding ways to treat and eventually to prevent Alzheimer's disease. Resources include: the Alzheimer's Association Green-Field Library, a research grants program, and the Journal of the Alzheimer's Association. | advocacy group, brain, brain health, clinical, dementia, alzheimers disease, community building portal, narrative resource, training material, database, training resource, service resource, FASEB list |
is related to: ADNI - Alzheimer's Disease Neuroimaging Initiative is related to: International Genomics of Alzheimers Project is parent organization of: General Practitioner Assessment of Cognition is parent organization of: Alzheimers Association Research Roundtable is parent organization of: Biomarkers Across Neurodegenerative Diseases is parent organization of: Alzheimer's Association International Research Grant Program is parent organization of: Informant Questionnaire on Cognitive Decline in the Elderly is parent organization of: IADRP is parent organization of: CADRO |
Alzheimer's disease, Aging | Public, Available to the research community | ISNI: 0000 0004 0614 7003, nif-0000-00451, Crossref funder ID: 100000957, grid.422384.b, Wikidata: Q4738818 | https://ror.org/0375f4d26 | SCR_007398 | Alzheimers Association, Alzheimer's Association | 2026-08-01 12:03:34 | 114 | |||||
|
Alzheimer Society of Canada Resource Report Resource Website 1+ mentions |
Alzheimer Society of Canada (RRID:SCR_000485) | institution | A nonprofit health organization that works to improve the quality of life of Canadians affected by Alzheimer's disease and other dementias. This organization also supports research on the cause and potential cures for the disease through education and funding. | dementia, alzheimer's, disease, research, funding, nonprofit, canada | Alzheimer's disease, Dementia | ISNI: 0000 0001 0702 2390, Crossref funder ID: 501100000143, nlx_158162, Wikidata: Q4738828, grid.453286.e | https://ror.org/03benss35 | SCR_000485 | 2026-08-01 12:01:23 | 2 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
